x
Visit our new Mobile Website next time you access NetDania with your mobile device

SAGE THERAPEUTICS INC. - COMMON STOCK

13.58
25-19:59:59 GMT
-0.42
-3.00%
Today's Range
13.56 - 14.97
ISIN:N/A

Figures - SAGE THERAPEUTICS INC. - COMMON STOCK

Open
13.62
Close
14.00
Year Change
-37.33
Year % Change
-37.33%
52 Week High
59.99
52 Week Low
10.92
Volume
1414569
Inc. Vol
187275

News - SAGE THERAPEUTICS INC. - COMMON STOCK

26-07:27 GMT
NEC FY Profit Rises
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-07:27 GMT
Anglo American Rejects BHP's GBP 31.1 Bln Buyout Proposal Citing Uncertainty And Complexity
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-07:27 GMT
Teladoc Health (TDOC) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-07:22 GMT
Copa Libertadores Winners And Losers After Matchday Three
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-07:22 GMT
Craig-Hallum Initiates Coverage of Red Robin Gourmet Burgers (RRGB) with Buy Recommendation
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-07:22 GMT
Leerink Partners Upgrades Tandem Diabetes Care (TNDM)
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-07:02 GMT
TotalEnergies Q1 Profit Up, Tops Market, Sales Down; Plans First Interim Dividend, $2 Bln Buyback
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-07:02 GMT
Kyocera FY Profit Declines
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-07:02 GMT
Nomura FY Net Income Rises
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:43 GMT
Real Madrid Vs. Real Sociedad Preview: Ancelotti Makes Big Lineup Rotations
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:43 GMT
One In Five Milk Samples From Across U.S. Had Traces Of Bird Flu Virus, FDA Says
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:38 GMT
Jenna Ortega’s Latest Movie Is Supposed To Be On Netflix. Where Is It?
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:34 GMT
Atomera (ATOM) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:34 GMT
NatWest Group Q1 Profit, Net Interest Income Drop; Retains Outlook
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:27 GMT
Goldman Sachs Upgrades TJX Companies (TJX)
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:27 GMT
Tesla Stock (NASDAQ:TSLA): Earnings Not as Good as the Reaction Suggests
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:09 GMT
Vikings Secure QB1, But J.J. McCarthy Must Take Charge Of Opportunity
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:05 GMT
KLA (KLAC) Q3 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:05 GMT
Snap (SNAP) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:05 GMT
Roku (ROKU) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:05 GMT
SKF Q1 Results Down, Adj. Margin Rises; Sees Weak Organic Sales In Q2, Backs FY24 View
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:05 GMT
Schibsted Enters Agreement With Polaris To Assume Full Ownership And Control Of FINN
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:05 GMT
DexCom (DXCM) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:05 GMT
Skechers U.s.a. (SKX) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:05 GMT
Annaly Capital Management (NLY) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-06:05 GMT
European Shares Seeking Rebound With Tech Earnings In Focus
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-05:42 GMT
Perplexity AI Raises $63 Million, Vision Pro Sales Slow, Meta Takes A Tumble
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-05:42 GMT
NVIDIA’s Acquisition Of Run:ai Emphasizes The Importance Of Kubernetes For Generative AI
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-05:39 GMT
Live Oak Bancshares (LOB) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-05:31 GMT
Unleashing AI Sounds: The Best Tools For Music, Voices, And Effects
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-05:15 GMT
SGS Q1 Sales Down, Organic Sales Rise; Confirms Outlook For FY24, Mid-term
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-05:15 GMT
Sensex, Nifty Struggle For Direction On Concerns Over US Economy
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-05:11 GMT
Battling Bell’s Palsy, Joel Embiid Scores Playoff Career-Best 50 Points In 76ers’ Game 3 Victory
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-04:56 GMT
Tycoon Tony Fernandes’ Capital A To Merge Airline Units In $1.4 Billion Deal
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-04:54 GMT
Why Jordan Morgan Was The Perfect Pick For The Green Bay Packers
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-04:31 GMT
Struggling David Warner A Concern For Australia Ahead Of Cricket T20 World Cup
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-04:26 GMT
Another Year, Another Panic-Filled Quarterback Draft
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-03:52 GMT
Arizona Cardinals Draft WR Marvin Harrison Jr. To Address Acute Need
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-03:51 GMT
‘Baby Reindeer’ Star Says Real Martha Searches Need To Stop
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
26-03:48 GMT
AZZ Prices Public Offering Of 4 Mln Shares At $70.00/shr - Quick Facts
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
38170.22
15.88
0.04%
5094.14
-7.84
-0.15%
17650.18
-45.8
-0.26%
64318.80
-174.2
-0.27%
18081.57
75.2
0.42%
38030.63
154.95
0.41%
3088.64
35.74
1.17%
8139.85
38.88
0.48%
17674.08
363.03
2.10%
7568.78
-32.92
-0.43%
22500.10
-70.25
-0.31%
2345.23
14.69
0.63%
89.42
0.24
0.27%
1.07297
0.00033
0.03%
156.770
1.15
0.74%
1.25077
0.00008
0.01%
0.65416
0.00199
0.31%
1.36470
-0.00123
-0.09%
168.20200
1.283
0.77%
0.85781
0.0002
0.02%
196.08200
1.446
0.74%
0.91171
-0.00099
-0.11%
0.97824
-0.00078
-0.08%
0.59597
0.0003
0.05%
105.68000
0.109
0.10%
Top Gainers
Name
Last
+/-
%
0.06
0.03
114.14%
0.08
0.04
95.12%
0.17
0.08
83.19%
0.16
0.07
77.78%
1.82
0.79
76.70%
0.22
0.07
51.98%
0.01
0.00
50.98%
2.43
0.81
50.00%
5.10
1.62
46.34%
0.05
0.02
42.86%
Top Losers
Name
Last
+/-
%
0.77
-2.14
-73.54%
0.01
-0.01
-45.83%
0.85
-0.65
-43.33%
0.26
-0.17
-38.87%
0.01
-0.01
-38.62%
0.03
-0.02
-38.00%
0.23
-0.12
-33.33%
0.02
-0.01
-33.00%
19.30
-9.42
-32.80%
0.17
-0.08
-31.00%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy